Quadrivalent HPV vaccination after effective treatment of Anal Intraepithelial Neoplasia in HIV+ men
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Mar 2018
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Anal intraepithelial neoplasia; Human papillomavirus infections
- Focus Therapeutic Use
- Acronyms VACCAIN-P
- 13 Mar 2018 Planned End Date changed from 1 Sep 2018 to 1 Jan 2019.
- 13 Mar 2018 Planned primary completion date changed from 1 Sep 2018 to 1 Jul 2018.
- 13 Mar 2018 Status changed from recruiting to active, no longer recruiting.